The effect of water solubility of solutes on their flux through human skin in vitro: An extended Flynn database fitted to the Roberts-Sloan equation

International Journal of Pharmaceutics

Volumn 339, Issue 1-2, 2007, Pages 157-167

  Thomas, Joshua ^a   Majumdar, Susruta ^a   Wasdo, Scott ^a   Majumdar, Antara ^b   Sloan, Kenneth B ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Flux; Human skin; In vitro; Lipid solubility; Roberts Sloan equation; Water solubility

Indexed keywords

ACECLOFENAC; ALDOSTERONE; AMINOPHENAZONE; ATENOLOL; BISOPROLOL; CELIPROLOL; CYCLOBARBITAL; DICLOFENAC; ESTRADIOL; FLUOROURACIL; FLURBIPROFEN; HYDROCORTISONE; IBUPROFEN; INDOMETACIN; ISOSORBIDE DINITRATE; KETOPROFEN; KETOROLAC; LIDOCAINE; METOPROLOL; NICORANDIL; OXPRENOLOL; PHENAZONE; PIROXICAM; PROGESTERONE; PROPRANOLOL; STEROID; TENOXICAM; TESTOSTERONE; THALIDOMIDE DERIVATIVE; UNINDEXED DRUG;

ARTICLE; DATA BASE; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MATHEMATICAL MODEL; MOLECULAR WEIGHT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN PERMEABILITY; SKINFOLD THICKNESS; SOLUTE;

DATABASES; HUMANS; PERMEABILITY; SKIN; SKIN ABSORPTION; SOLUBILITY;

EID: 34250902538     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.02.031     Document Type: Article

References (44)

1. Abraham M.H., Martins F., and Mitchell R.C. Algorithms for skin permeability using hydrogen bond descriptors: the problem of steroids. J. Pharm. Pharmacol. 49 (1997) 858-865
2. Abraham M.H., and Martins F. Human skin permeation and partition: general linear free-energy relationship analyses. J. Pharm. Sci. 93 (2004) 1508-1523
3. Anderson B.D., Higuchi W.I., and Raykar P.V. Heterogeneity effects on permeability-partition coefficient relationships in human stratum corneum. Pharm. Res. 5 (1988) 566-573
4. Anderson B.D., and Raykar P.V. Solute structure-permeability relationships in human stratum corneum. J. Invest. Dermatol. 93 (1989) 280-286
5. Bronaugh R.L., and Congden E.R. Percutaneous absorption of hair dyes: correlation with partition coefficients. J. Invest. Dermatol. 83 (1984) 124-127
6. Buchwald P., and Bodor N. A simple, predictive, structure based skin permeability model. J. Pharm. Pharmacol. 53 (2001) 1087-1098
7. Cordero J.A., Alarcon L., Escribano E., Obach R., and Domenech J. A comparative study of the transdermal penetration of a series of nonsteroidal antiiflammatory drugs. J. Pharm. Sci. 86 (1997) 503-508
8. Dal Pozzo A., Donzelli G., Liggeri E., and Rodriguez L. Percutaneous absorption of nicotinic acid derivatives in vitro. J. Pharm. Sci. 80 (1991) 54-57
9. Dal Pozzo A., Liggeri E., Delucca C., and Calabrese G. Prediction of skin permeation of highly lipophilic compounds: in vitro model with a modified receptor phase. Int. J. Pharm. 70 (1991) 219-223
10. Dal Pozzo A., and Pastori N. Percutaneous absorption of parabens from cosmetic formulations. Int. J. Cosmet. Sci. 18 (1996) 57-66
11. Degim T., Pugh W.J., and Hadgraft J. Skin permeability data: anomalous results. Int. J. Pharm. 170 (1998) 129-133
12. Flynn G.L. Physicochemical determinates of skin absorption. In: Gerrity J.R., and Henry C.J. (Eds). Principles of Route-to-Route Extrapolation for Risk Assessment (1990), Elsevier, Amsterdam 93-127
13. Geinoz S., Guy R.H., Testa B., and Carrupt P.A. Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical evaluation. Pharm. Res. 21 (2004) 83-92
14. Goosen C., Laing T.J., du Plessis J., Goosen T.C., Lu G.-W., and Flynn G.L. Physicochemical characterization and solubility analysis of thalidomide and its N-alkyl analogs. Pharm. Res. 19 (2002) 13-19
15. Goosen C., Laing T.J., du Plessis J., Goosen T.C., Lu G.-W., and Flynn G.L. Percutaneous delivery of thalidomide and its N-alkyl analogs. Pharm. Res. 19 (2002) 434-439
16. Guy R.H., Carlstrom E.M., Bucks D.A.W., Hinz R.S., and Maibach H.I. Percutaneous penetration of nicotinates: in vitro and in vitro measurements. J. Pharm. Sci. 75 (1986) 968-972
17. Gyurosiova L., Laitinen L., Raiman J., Cizmarik J., Sedlarova E., and Hirvonin. Permeability profiles of M-alkoxysubstituted pyrrolidinoethyl esters of phenylcarbamic acid across Caco-2 monolyaers and human skin. Pharm. Res. 19 (2002) 162-168
18. Hadgraft J., and Ridout G. Development of model membranes for percutaneous absorption measurements. I. Isopropyl myristate. Int. J. Pharm. 39 (1987) 149-156
19. Hansch C., and Lien E.J. Structure-activity relationships in antifungal agents: a survey. J. Med. Chem. 14 (1971) 653-670
20. Higuchi T. Physical chemical analyses of percutaneous absorption process from creams and ointments. J. Soc. Cosmet. Chem. 11 (1960) 85-97
21. Johnson M.E., Blankschtein D., and Langer R. Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism. J. Pharm. Sci. 86 (1997) 1162-1172
22. Kasting G.B., Smith R.L., and Anderson B.D. Prodrugs for dermal delivery: solubility, molecular size and functional group effects. In: Sloan K.B. (Ed). Prodrugs: Topical and Ocular Drug Delivery (1992), Marcel Dekker, New York 117-161
23. Kasting G.B., Smith R.L., and Cooper E.R. Effect of lipid solubility and molecular size on percutaneous absorption. In: Shroot B., and Schaefer H. (Eds). Pharmacology and The Skin vol. 1 (1987), Karger, Basel 138-153
24. Le V.A., and Lippold B.C. Influence of physicochemical properties of homologeous esters of nicotinic acid on skin permeability and maximum flux. Int. J. Pharm. 124 (1995) 285-292
25. Magnusson B.M., Anissimov Y.G., Cross S.E., and Roberts M.S. Molecular size as the main determinant of solute maximum flux across the skin. J. Invest. Dermatol. 122 (2004) 993-999
26. Majumdar S., Thomas J., Wasdo S.C., and Sloan K.B. The effect of water solubility of solutes on their flux through human in vitro. Int. J. Pharm. 329 (2007) 25-36
27. Michaels A.S., Chandrasekaran S.K., and Shaw J.E. Drug permeation through human skin: theory and in vitro experimental measurement. Am. Inst. Chem. Eng. 21 (1975) 985-996
28. Modamio P., Lastra C.F., and Marino E.L. Trasdermal absorption of Celiprolol and Bisoprolol in human skin in vitro. Int. J. Pharm. 173 (1998) 141-148
29. Modamio P., Lastra C.F., and Marino E.L. A Comparative in vitro study of percutaneous penetration of β-blockers in human skin. Int. J. Pharm. 194 (2000) 249-259
30. Morimoto Y., Hatanaka T., Sugibayashi K., and Omiya H. Prediction of skin permeability of drugs: comparison of human and hairless rat skin. J. Pharm. Pharmacol. 44 (1992) 634-639
31. Moss G.P., and Cronin M.T.D. Quantitative structure-permeability relationships for percutaneous absorption: re-analysis of steroid data. Int. J. Pharm. 238 (2002) 105-109
32. Ni N., Sanghvi T., and Yalkowsky S.H. Independence of the product of solubility and distribution coefficient of pH. Pharm. Res. 19 (2002) 663-669
33. Roberts M., Anderson R., and Swarbrick J. Permeability of human epidermis to phenolic compounds. J. Pharm. Pharmacol. 29 (1977) 677-683
34. Roberts W.J., and Sloan K.B. Correlation of aqueous and lipid solubilities with flux for prodrugs of 5-fluorouracil, theophylline and 6-mercaptopurine: a Potts-Guy approach. J. Pharm. Sci. 88 (1999) 515-532
35. Roy S.D., and Flynn G.L. Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin. Pharm. Res. 6 (1989) 825-832
36. Roy S.D., Fujiki J., and Fleitman J.S. Permeabilities of alkyl p-aminobenzoates through living skin equivalents and cadaver skin. J. Pharm. Sci. 82 (1993) 1266-1268
37. Scheuplein R.J., and Blank I.H. Permeability of the skin. Physiol. Rev. 51 (1971) 702-747
38. Scheuplein R., and Blank I. Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. J. Invest. Dermatol. 60 (1973) 286-296
39. Scheuplein R.J., Blank I.H., and MacFarlane D.J. Percutaneous absorption of steroids. J. Invest. Dermatol. 52 (1969) 63-70
40. Siddiqui O., Roberts M., and Polack A. Percutaneous absorption of steroids: relative contributions of epidermal penetration and dermal clearance. J. Pharmacokinet. Biopharm. 17 (1989) 405-424
41. Singh P., and Roberts M.S. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J. Pharm. Exp. Ther. 268 (1994) 144-151
42. Sloan K.B., Wasdo S.C., and Rautio J. Design for optimized topical delivery: prodrugs and a paradigm change. Pharm. Res. 23 (2006) 2729-2747
43. Yalkowsky S., and Valvani S. Solubility and partitioning. 1. Solubility of nonelectrolytes in water. J. Pharm. Sci. 69 (1980) 912-922
44. Yalkowsky S.H., Valvani S.C., and Roseman T.J. Solubility and patitioning. VI. Octanol solubility and octanol:water partition coefficients. J. Pharm. Sci. 72 (1983) 866-870